Targeting BCL-2 in Hematologic Malignancies
Crossref DOI link: https://doi.org/10.1007/s11523-018-0560-7
Published Online: 2018-03-08
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Khan, Nadia
Kahl, Brad
Text and Data Mining valid from 2018-03-08
Article History
First Online: 8 March 2018
Compliance and Ethical Standards
:
: Dr. Kahl has consulted for Abbvie and Pharamcyclics. Dr. Khan has consulted for Gilead and Abbvie.